Global Axial Spondyloarthritis (axSpA) Market Report 2023
30 janv. 2024 20h24 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis (axSpA) Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global axial...
Generic Musculoskeletal Disorders Drugs Global Market Report 2023: High Prevalence of Arthritis is Expected to Propel Growth
24 mai 2023 10h13 HE
|
Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Generic Musculoskeletal Disorders Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
JAK Inhibitors Competitive Landscape 2023: Comprehensive Insights on 40+ Companies and 45+ Drug Profiles
08 mai 2023 06h38 HE
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "JAK inhibitors - Competitive Landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "JAK inhibitors - Competitive landscape,...
China Anti-Rheumatic Drug Market Forecasts Report 2022-2027 - Growing Prevalence of Rheumatic Patients Leading to Increased Demand
20 janv. 2023 06h58 HE
|
Research and Markets
Dublin, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The "China Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.China Antirheumatic Drugs...
Brazil Anti-Rheumatic Drug Market Forecasts Report 2022: A $2.83 Billion Market by 2027 - Aging Populations Driving Demand
17 janv. 2023 07h38 HE
|
Research and Markets
Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The Brazilian...
Global Hydroxychloroquine Global Market Outlook 2021 to 2030: Key Players Include Bayer, Novartis, Mylan and Sanofi
30 déc. 2021 06h08 HE
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hydroxychloroquine Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....